Plexium

Drug Discovery · San Diego, CA · Founded 2017 · Privately Held (backing)

Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. Plexium is based in San Diego, CA and was founded in 2017. It was valued at $200 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $225 million across 2 recorded rounds; the latest was a $60.1 million later-stage round in Jul 2025.

PMV mark · valuation
$200.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$225.1M
Last round
Later Stage VC
Jul 2025
What is Plexium worth?
$200.0MPrivateMarketView mark · Oct 2026

Valued at $200.0M at its later-stage round, Aug 2025. Nothing has traded since.

Free account
More of Plexium with a free account
  • ·The complete investor list: 18 names
  • ·Watch Plexium: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Plexium funding history

2 rounds
DateRoundRaisedPost-money
Jul 2025Later Stage VC$60.1M▮
Feb 2022Later Stage VC (Series B)$102.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Plexium valuation

Plexium was valued at $200 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Plexium raised?

Plexium has raised $225 million in total; 2 of its rounds are on record. The largest on record was a $60.1 million later-stage round in Jul 2025.

Plexium has filed 1 Form D with the SEC, most recently in Aug 2025 ($60.1 million sold to 20 investors).

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Adcytherix ($213 million), Adcendo ($210 million) and Ajax Therapeutics ($193 million).

How Plexium's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Plexium, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Plexium

What is Plexium worth?
Plexium is valued at $200.0M as of Oct 2026. Valued at $200.0M at its later-stage round, Aug 2025. Nothing has traded since.
How much has Plexium raised?
Plexium has raised $225.1M in total funding across 2 recorded rounds.
When did Plexium last raise?
Plexium last raised in Jul 2025 (Later Stage VC), raising $60.1M.